BELLADONNA, Maria Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.668
EU - Europa 3.092
AS - Asia 2.357
SA - Sud America 404
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 9.584
Nazione #
US - Stati Uniti d'America 3.578
SG - Singapore 993
IT - Italia 831
IE - Irlanda 471
CN - Cina 385
HK - Hong Kong 382
UA - Ucraina 358
BR - Brasile 345
VN - Vietnam 295
SE - Svezia 270
DE - Germania 246
RU - Federazione Russa 233
FI - Finlandia 149
RO - Romania 126
FR - Francia 120
KR - Corea 93
GB - Regno Unito 77
CA - Canada 56
IN - India 48
BE - Belgio 39
CZ - Repubblica Ceca 32
CH - Svizzera 27
JP - Giappone 27
PL - Polonia 27
NL - Olanda 26
AR - Argentina 24
TR - Turchia 21
MX - Messico 20
AT - Austria 17
ES - Italia 14
CI - Costa d'Avorio 13
EG - Egitto 13
IR - Iran 13
UZ - Uzbekistan 13
EC - Ecuador 12
ID - Indonesia 11
BD - Bangladesh 10
GR - Grecia 9
IQ - Iraq 8
LB - Libano 8
PK - Pakistan 8
ZA - Sudafrica 8
EU - Europa 7
JO - Giordania 7
MA - Marocco 7
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
PY - Paraguay 5
IL - Israele 4
TN - Tunisia 4
CL - Cile 3
CO - Colombia 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DK - Danimarca 2
GA - Gabon 2
JM - Giamaica 2
KH - Cambogia 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CU - Cuba 1
CV - Capo Verde 1
GD - Grenada 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 9.584
Città #
Singapore 672
Perugia 507
Chandler 506
Dublin 466
Hong Kong 380
San Mateo 244
Dong Ket 194
Jacksonville 194
Boardman 187
Ashburn 167
Santa Clara 160
Bucharest 118
Beijing 113
Redmond 113
Munich 103
Medford 101
Wilmington 101
Princeton 100
Seoul 90
Ann Arbor 86
Altamura 83
Moscow 78
Lawrence 75
Los Angeles 73
New York 59
Andover 57
Des Moines 48
Falls Church 45
Brussels 39
Ho Chi Minh City 38
Piscataway 37
The Dalles 36
Dearborn 30
Turku 30
Helsinki 29
Saint Petersburg 28
São Paulo 28
Chennai 26
Pisa 26
Dallas 24
Woodbridge 23
Norwalk 22
Nuremberg 22
Warsaw 22
Chicago 21
Tokyo 21
Denver 20
Poplar 19
Atlanta 18
Ottawa 18
San Paolo di Civitate 18
Fremont 17
Brno 15
Brooklyn 15
Montreal 15
Stockholm 15
Bologna 14
Boston 14
Houston 14
Olomouc 14
Abidjan 13
Columbus 13
Vicenza 13
Rome 12
Haiphong 11
Hanoi 11
Lappeenranta 11
Milan 11
Hefei 10
Izmir 10
Falkenstein 9
Parma 9
Redwood City 9
San Diego 9
San Francisco 9
San Jose 9
Toronto 9
London 8
Phoenix 8
Seattle 8
Brasília 7
Chiajna 7
Guangzhou 7
Rio de Janeiro 7
Amman 6
Chengdu 6
Curitiba 6
Den Haag 6
Fortaleza 6
Frankfurt am Main 6
Johannesburg 6
Manchester 6
Orem 6
Paris 6
Querétaro 6
Shanghai 6
Tianjin 6
Vienna 6
Amsterdam 5
Belo Horizonte 5
Totale 6.172
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 187
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 177
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 176
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 173
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 165
Amino-acid sensing and degrading pathways in immune regulation 162
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 158
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 155
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 151
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 149
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 135
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 132
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 129
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 125
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 125
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 119
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 118
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 115
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 113
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 112
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 111
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 111
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 108
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 106
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 105
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 104
Anti-osteoclastogenic activity of Crocus sativus petal extract: turning saffron waste into a valuable resource against bone disruption. 102
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 101
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 100
The TGF-β/IDO axis in infectious tolerance. 100
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 100
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 98
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 98
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 98
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 97
IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance 97
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 97
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 93
Modulation of tryptophan catabolism by regulatory T cells 91
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 91
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 89
Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. 89
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 88
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 86
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 86
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 86
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer 86
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 85
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 84
Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents. 84
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 83
Crocus sativus L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell Model 83
Anti-inflammatory and anti-osteoclastogenic activity of a Crocus sativus petal extract targeting macrophages: from waste to raw material on the way to preventing bone loss. Maria 81
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 81
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 80
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 80
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 79
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 77
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 76
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 75
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 75
CTLA-4-Ig regulates tryptophan catabolism in vivo. 73
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 72
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 72
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 72
Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. 72
METODO PER LA REALIZZAZIONE DI UNA COMPOSIZIONE PER USO FARMACEUTICO COMPRENDENTE CELLULE DENDRITICHE E COMPOSIZIONE PER USO FARMACEUTICO COSI' OTTENUTA 71
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 71
The IL-23/IL-17 pathway impairs antifungal immune resistance 70
Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. 70
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. 70
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 70
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 69
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 69
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 69
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 69
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 69
Potentent antitumor activity of interleukin-27. 68
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 68
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 68
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 67
T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. 67
Current Challenges for IDO2 as Target in Cancer Immunotherapy 67
IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. 66
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 66
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 65
Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. 65
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 65
The role of TGF-beta as tolerogenic cytokine in regulating dendritic cell function. 64
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 63
Negative vaccination with IGRP-pulsed dendritic cells expressing ectopic IL-35Ig prevents the development of NOD autoimmune Diabetes 63
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 62
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. 62
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 61
Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. 61
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. 61
PRODUCTION OF MEMBRANE AND SOLUBLE PD-L1 BY LUNG TUMOR CELLS 61
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 60
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 56
IL-23 gene therapy for mouse bladder tumour cell lines. 56
Totale 9.207
Categoria #
all - tutte 43.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 0 65 95 10 109 38 76 209
2021/20221.242 19 179 20 48 55 31 14 276 153 102 117 228
2022/20231.660 112 283 12 153 151 173 1 81 611 17 49 17
2023/2024757 37 92 25 11 11 12 199 22 77 19 88 164
2024/20251.958 47 155 148 118 206 88 128 207 300 109 269 183
2025/20262.082 269 294 237 619 523 140 0 0 0 0 0 0
Totale 9.932